Public Employees Retirement System of Ohio Sells 5,558 Shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Public Employees Retirement System of Ohio lessened its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report) by 7.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 73,389 shares of the medical instruments supplier’s stock after selling 5,558 shares during the period. Public Employees Retirement System of Ohio’s holdings in DENTSPLY SIRONA were worth $1,986,000 at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Raymond James Trust N.A. grew its holdings in shares of DENTSPLY SIRONA by 4.9% during the 2nd quarter. Raymond James Trust N.A. now owns 9,658 shares of the medical instruments supplier’s stock valued at $241,000 after purchasing an additional 453 shares during the last quarter. State of Alaska Department of Revenue grew its stake in shares of DENTSPLY SIRONA by 2.4% during the third quarter. State of Alaska Department of Revenue now owns 23,545 shares of the medical instruments supplier’s stock worth $637,000 after buying an additional 560 shares during the last quarter. LRI Investments LLC increased its holdings in shares of DENTSPLY SIRONA by 82.7% during the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock worth $31,000 after buying an additional 564 shares in the last quarter. MML Investors Services LLC lifted its stake in shares of DENTSPLY SIRONA by 2.1% in the 3rd quarter. MML Investors Services LLC now owns 29,682 shares of the medical instruments supplier’s stock valued at $803,000 after acquiring an additional 620 shares during the last quarter. Finally, Allworth Financial LP boosted its holdings in shares of DENTSPLY SIRONA by 40.2% during the 3rd quarter. Allworth Financial LP now owns 2,179 shares of the medical instruments supplier’s stock valued at $59,000 after acquiring an additional 625 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Performance

Shares of DENTSPLY SIRONA stock opened at $19.19 on Wednesday. The business has a 50-day moving average price of $21.18 and a two-hundred day moving average price of $24.11. DENTSPLY SIRONA Inc. has a 1-year low of $17.21 and a 1-year high of $37.60. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. The company has a market cap of $3.81 billion, a P/E ratio of -9.28, a PEG ratio of 1.93 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAYGet Free Report) last released its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 EPS for the quarter, topping the consensus estimate of $0.48 by $0.02. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. The business had revenue of $951.00 million during the quarter, compared to analysts’ expectations of $939.10 million. During the same quarter last year, the firm posted $0.49 earnings per share. The firm’s revenue was up .4% on a year-over-year basis. As a group, analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, January 10th. Investors of record on Friday, December 27th will be given a dividend of $0.16 per share. The ex-dividend date of this dividend is Friday, December 27th. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.34%. DENTSPLY SIRONA’s payout ratio is presently -30.92%.

Analyst Ratings Changes

A number of brokerages have recently commented on XRAY. Barrington Research cut their price target on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research note on Friday, November 8th. Mizuho assumed coverage on shares of DENTSPLY SIRONA in a research report on Wednesday, December 4th. They set a “neutral” rating and a $21.00 target price on the stock. Robert W. Baird decreased their price target on shares of DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. StockNews.com cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Finally, Leerink Partnrs lowered DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research report on Thursday, November 7th. Eight analysts have rated the stock with a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $27.91.

Read Our Latest Analysis on DENTSPLY SIRONA

DENTSPLY SIRONA Company Profile

(Free Report)

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.

Featured Articles

Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAYFree Report).

Institutional Ownership by Quarter for DENTSPLY SIRONA (NASDAQ:XRAY)

Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.